Australia markets open in 54 minutes

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
38.97+0.26 (+0.67%)
At close: 04:00PM EDT
39.77 +0.80 (+2.05%)
After hours: 06:52PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6665
Avg. Estimate0.70.733.694.56
Low estimate0.630.693.614.41
High estimate0.830.83.774.67
Year ago EPS0.470.742.773.69
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts9998
Avg. Estimate199.78M207.53M952.44M1.09B
Low estimate180.72M196M943.09M1.07B
High estimate220M223M966.56M1.1B
Year ago sales175.51M199.95M829.25M952.44M
Sales growth (year/est)13.80%3.80%14.90%14.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS0.480.630.710.82
Actual EPS0.470.740.750.82
Difference-0.010.110.040
Surprise %-2.10%17.50%5.60%0.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.70.733.694.56
7 days ago0.70.733.694.56
30 days ago0.760.793.684.58
60 days ago0.770.813.554.43
90 days ago0.870.863.514.34
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 days11N/AN/A
Growth estimatesHALOIndustrySector(s)S&P 500
Current qtr.48.90%N/AN/AN/A
Next qtr.-1.40%N/AN/AN/A
Current year33.20%N/AN/AN/A
Next year23.60%N/AN/AN/A
Next 5 years (per annum)25.00%N/AN/AN/A
Past 5 years (per annum)84.82%N/AN/AN/A